AU2006279863A1 - Silylamine modified nanoparticulate carriers - Google Patents

Silylamine modified nanoparticulate carriers Download PDF

Info

Publication number
AU2006279863A1
AU2006279863A1 AU2006279863A AU2006279863A AU2006279863A1 AU 2006279863 A1 AU2006279863 A1 AU 2006279863A1 AU 2006279863 A AU2006279863 A AU 2006279863A AU 2006279863 A AU2006279863 A AU 2006279863A AU 2006279863 A1 AU2006279863 A1 AU 2006279863A1
Authority
AU
Australia
Prior art keywords
composition according
core
particles
colloid
silylamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006279863A
Other languages
English (en)
Inventor
Joseph Francis Bringley
Tiecheng Alex Qiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carestream Health Inc
Original Assignee
Carestream Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carestream Health Inc filed Critical Carestream Health Inc
Publication of AU2006279863A1 publication Critical patent/AU2006279863A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C17/00—Surface treatment of glass, not in the form of fibres or filaments, by coating
    • C03C17/28—Surface treatment of glass, not in the form of fibres or filaments, by coating with organic material
    • C03C17/30—Surface treatment of glass, not in the form of fibres or filaments, by coating with organic material with silicon-containing compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C11/00—Multi-cellular glass ; Porous or hollow glass or glass particles
    • C03C11/002—Hollow glass particles
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y10T428/2995—Silane, siloxane or silicone coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Geochemistry & Mineralogy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2006279863A 2005-08-18 2006-08-11 Silylamine modified nanoparticulate carriers Abandoned AU2006279863A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/206,362 US20070292688A1 (en) 2005-08-18 2005-08-18 Silylamine modified nanoparticulate carriers
US11/206,362 2005-08-18
PCT/US2006/031397 WO2007021946A2 (en) 2005-08-18 2006-08-11 Silylamine modified nanoparticulate carriers

Publications (1)

Publication Number Publication Date
AU2006279863A1 true AU2006279863A1 (en) 2007-02-22

Family

ID=37758211

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006279863A Abandoned AU2006279863A1 (en) 2005-08-18 2006-08-11 Silylamine modified nanoparticulate carriers

Country Status (6)

Country Link
US (1) US20070292688A1 (https=)
EP (1) EP1915423A2 (https=)
JP (1) JP2009504742A (https=)
CN (1) CN101263191A (https=)
AU (1) AU2006279863A1 (https=)
WO (1) WO2007021946A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116603462A (zh) * 2023-05-22 2023-08-18 哈尔滨理工大学 一种HGMs@Al2O3复合微球及制备方法和在构筑三维隔热结构水性隔热涂料中的应用

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE536993T1 (de) 2002-01-02 2011-12-15 Visen Medical Inc Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten
WO2007136413A2 (en) * 2005-12-22 2007-11-29 Visen Medical, Inc. Biocompatible fluorescent metal oxide nanoparticles
EP2030632A1 (en) * 2007-09-03 2009-03-04 UMC Utrecht Holding B.V. A carrier particle for use in bio-applications
AU2009248810B2 (en) * 2008-05-23 2013-12-05 The Regents Of The University Of Michigan Nanoemulsion vaccines
EP2293814A4 (en) * 2008-05-23 2013-02-13 Univ Michigan NANOEMULSION AGENTS
EP2349209A2 (en) 2008-09-26 2011-08-03 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
JP5203132B2 (ja) * 2008-10-21 2013-06-05 古河電気工業株式会社 架橋性官能基を粒子表面に有するシリカ粒子の製造方法、架橋性官能基を粒子表面に有するシリカ粒子、前記シリカ粒子のコロイド、前記シリカ粒子を用いた複合粒子、及び前記複合粒子の製造方法
IT1398194B1 (it) 2008-10-22 2013-02-14 Univ Degli Studi Torino Cianina funzionalizzata con braccio di legame silanico, procedimento per la sua preparazione e suoi usi
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
ES2647567T3 (es) * 2008-12-29 2017-12-22 General Electric Company Agentes de contraste de nanopartículas para el diagnóstico por imágenes
BRPI1014031A2 (pt) * 2009-06-16 2018-02-20 Univ Michigan Regents vacinas de nanoemulsão
CN107375214B (zh) * 2017-07-27 2020-07-28 重庆医科大学 一种载药的叶酸修饰蒙脱石纳米制剂及其制备方法
MX2021005462A (es) * 2018-11-09 2021-08-24 Arbutus Biopharma Corp Lipidos cationicos que contienen silicio.
CN109540859B (zh) * 2018-11-27 2021-02-09 上海交通大学 一种水体中抗生素的分析和含量预测方法
WO2020110481A1 (ja) 2018-11-30 2020-06-04 パナソニックＩｐマネジメント株式会社 複合体及び検出装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760126A (en) * 1996-12-20 1998-06-02 Minnesota Mining And Manufacturing Company Aqueous fluorochemical compositions and abrasion-resistant coatings therefrom
WO1998051435A1 (en) * 1997-05-14 1998-11-19 Weixin Tang Fully-coated, uniform-sized metallic particles
US6692123B2 (en) * 2001-08-31 2004-02-17 Eastman Kodak Company Ink jet printing method
US7189417B2 (en) * 2002-05-01 2007-03-13 The Trustees Of The University Of Pennsylvania Nanometer-sized carrier medium
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US20040115239A1 (en) * 2002-09-20 2004-06-17 Shastri Venkatram P. Engineering of material surfaces
US7109247B2 (en) * 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US20050014851A1 (en) * 2003-07-18 2005-01-20 Eastman Kodak Company Colloidal core-shell assemblies and methods of preparation
US6890610B2 (en) * 2003-07-18 2005-05-10 Eastman Kodak Company Inkjet recording element
US20060293396A1 (en) * 2005-01-14 2006-12-28 Eastman Kodak Company Amine polymer-modified nanoparticulate carriers

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116603462A (zh) * 2023-05-22 2023-08-18 哈尔滨理工大学 一种HGMs@Al2O3复合微球及制备方法和在构筑三维隔热结构水性隔热涂料中的应用
CN116603462B (zh) * 2023-05-22 2025-06-06 哈尔滨理工大学 一种HGMs@Al2O3复合微球及制备方法和在构筑三维隔热结构水性隔热涂料中的应用

Also Published As

Publication number Publication date
US20070292688A1 (en) 2007-12-20
JP2009504742A (ja) 2009-02-05
WO2007021946A3 (en) 2007-06-07
WO2007021946A2 (en) 2007-02-22
EP1915423A2 (en) 2008-04-30
CN101263191A (zh) 2008-09-10

Similar Documents

Publication Publication Date Title
US20080241266A1 (en) Amine polymer-modified nanoparticulate carriers
US7541017B2 (en) Amine polymer-modified nanoparticulate carriers
US20070292688A1 (en) Silylamine modified nanoparticulate carriers
EP2000150B1 (en) Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
US9028880B2 (en) Silica nanoparticle agent conjugates
US20080095699A1 (en) Imaging contrast agents using nanoparticles
WO2008036117A2 (en) Nanogel contrast agents for optical molecular imaging
Grebenik et al. Upconversion nanoparticles and their hybrid assemblies for biomedical applications
EP3154521B1 (en) Disintegratable core/shell silica particles for encapsulating and releasing bioactive macromolecules
US10888630B2 (en) Magnetic nanoparticles functionalized with catechol, production and use thereof
US20110060269A1 (en) Method for killing cells using photocatalytic titanium dioxide particles
CN109395678A (zh) 物质包封微囊及其制备方法
Zhang et al. Optimizing the polymer cloak for upconverting nanoparticles: an evaluation of bioactivity and optical performance
De Marchi et al. IgG functionalized polymeric nanoparticles for oral insulin administration
US9504761B2 (en) Stabilized chitosan-based nanoparticles and methods for making the same
CN109091468B (zh) 一种抗体、多肽和核酸组合治疗靶向载体及制法和用途
Ahmed et al. Influence of enantiomeric polylysine grafted on gold nanorods on the uptake and inflammatory response of bone marrow‐derived macrophages in vitro
WO2025021705A2 (en) Coated nanoparticles and their use for delivery of therapeutic and diagnostic agents
JP4169078B2 (ja) 酸化チタン複合体粒子、その分散液、およびそれらの製造方法
Zayed et al. Growth factor loaded functionalized gold nanoparticles as potential targeted treatment for acute renal failure
Abtahi Surface Modification of NaLnF4 and NbO2 Nanoparticles With Bisphosphonate Derivatives for Mass Cytometry Applications
Khullar et al. Hemolytic Assay of Biocompatible Nanomaterials in Drug Delivery Systems
Kostiv Design and characterization of advanced polymer-coated upconversion nanoparticles
JP2006150345A (ja) 光触媒性二酸化チタン微粒子
EP2148701A2 (en) Imaging contrast agents using nanoparticles

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period